Buccal cell screening with AI heatmap to detect early lung cancer
Official title: Translating buccal nanocytology for lung cancer screening into clinical practice
Funded at Northwestern University · NIH-11381218 · Data updated 2026-11-12
A home-based cheek-swab test using AI analysis of cheek cell DNA architecture aims to flag people at risk for early lung cancer so they can get confirmatory imaging like CT scans.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northwestern University NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project start | April 15, 2018 |
| Project end | July 31, 2029 |
| Funding year | 2026 |
| Award (this year) | $667,591 |
| NIH project number | 7R01CA225002-09 |
| Project ID | NIH-11381218 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults with risk factors for lung cancer, including a history of smoking or exposure, who are willing to perform a self-administered cheek swab and follow up with medical testing if indicated.
✕Less likely to help
Individuals without cancer or those unable to perform a cheek swab may not benefit from this screening approach.
What this research studies
This project develops a self-administered at-home screening method that analyzes chromatin patterns in buccal cells to identify people at risk for early-stage lung cancer. It uses 3D AI-enhanced analysis to interpret nanoscale chromatin changes and guide follow-up testing such as CT scans. The approach focuses on practicality and accessibility so individuals can screen outside traditional medical settings. If successful, it could help catch cancers earlier when treatments are more effective.
Why it matters
Potential benefit: If successful, patients could detect lung cancer earlier through an easy at-home test and pursue timely imaging and treatment.
How similar studies have gone: Prior noninvasive screening methods have shown potential in early detection, but this specific buccal-cell, AI-driven approach remains investigational and its effectiveness is being evaluated.
Where this research is happening
-
Northwestern University
Chicago, United States Active
Researchers
- Principal investigator: Backman, Vadim — Northwestern University
- Study coordinator: Backman, Vadim
Related research
Other NIH-funded projects on the same topics.
-
Digital health strategies to expand lung cancer screening in safety-net clinics
A funded project aims to help low-resource clinics increase the use of lung cancer screening for patients who smoke or are at risk.
-
Integrated approach to lung screening and quitting for African Americans
A multi-level program aims to boost LDCT lung cancer screening uptake and help African American smokers quit, with support from a comprehensive community-focused plan.
-
Population health approach to boost lung cancer screening at community clinics
A large Utah project aims to help community clinics reach more eligible adults to get low-dose CT lung cancer screening.
-
Group-based tobacco treatment for older adults after lung cancer screening
A study tests a group-based tobacco cessation program for older adults who are getting lung cancer screening to help them quit smoking.
-
Personalized Lung Cancer Screening for Veterans
Aimed at improving who gets screened and how lung cancer is diagnosed among Veterans using personalized tools.
-
Proteogenomic framework to improve lung cancer screening with biomarkers
A biomarker-based approach aims to refine LDCT lung cancer screening so more cancers are caught early while reducing unnecessary procedures.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.